Verition Fund Management
ORIC icon

Verition Fund Management’s Oric Pharmaceuticals ORIC Stock Holding History

Verition Fund Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,205
Closed -$276K – 3613
2024
Q4 		$276K Sell
34,205
-8,775
-20% -$80.5K ﹤0.01% 2816
2024
Q3 		$441K Buy
42,980
+8,752
+26% +$86.5K ﹤0.01% 2396
2024
Q2 		$242K Buy
+34,228
New +$306K ﹤0.01% 2482
2023
Q4 		– Sell
-24,400
Closed -$148K – 2592
2023
Q3 		$148K Buy
24,400
+20
+0.1% +$164 ﹤0.01% 2055
2023
Q2 		$189K Buy
24,380
+11,055
+83% +$62.8K ﹤0.01% 1874
2023
Q1 		$76K Buy
+13,325
New +$69.6K ﹤0.01% 1933

Other funds holding ORIC

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Verition Fund Management's ORIC Position: Q1 2025 in Review

Verition Fund Management sold out of Oric Pharmaceuticals (ORIC) in Q1 2025, closing a stake of 34,205 shares — an estimated $276K sold.

Verition Fund Management first reported a position in ORIC in Q1 2023 and held it in 6 quarters. The position peaked at $441K in Q3 2024. 143 funds tracked by Wall St. Rank hold ORIC as of Q1 2025.

  • Verition Fund Management reported no remaining Oric Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 34,205 Oric Pharmaceuticals shares in Q1 2025, an estimated $276K.
  • Verition Fund Management first reported a position in Oric Pharmaceuticals in Q1 2023 and held it in 6 quarters.
  • Verition Fund Management's Oric Pharmaceuticals position peaked at $441K in Q3 2024.
  • 143 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.